Concepedia

Matthew T. Taber

MT

18

Publications

1.1K

Citations

15

H-Index

1993

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of British Columbia

Bristol-Myers Squibb (Germany)

Matthew T. Taber is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryBiochemistryNeuropharmacologyNeurosciencePharmacotherapyNatural SciencesMolecular PharmacologySocial Sciences

Publications per year

1993–2013

18

Publications

18

Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels

Valentin K. Gribkoff, John E. Starrett, Steven I. Dworetzky et al. · Nature Medicine · 2001 · 308 citations

Cerebrovascular Disease, Social Sciences, Cerebral Vascular Regulation +16

Cortical Regulation of Subcortical Dopamine Release: Mediation via the Ventral Tegmental Area

Matthew T. Taber, Sheela Das, Hans C. Fibiger · Journal of Neurochemistry · 1995 · 258 citations

Brain Mechanism, Cortical Regulation, Neurotransmitter +22

Electrical Stimulation of the Medial Prefrontal Cortex Increases Dopamine Release in the Striatum

Matthew T. Taber, Hans C. Fibiger · Neuropsychopharmacology · 1993 · 98 citations · Full text

Neurobiological Mechanism, Electrical Stimulation, Psychiatry +9

Glutamate receptor agonists decrease extracellular dopamine in the rat nucleus accumbens in vivo

Matthew T. Taber, Glen B. Baker, Hans C. Fibiger · Synapse · 1996 · 51 citations

Dinapsoline: Characterization of a D1 Dopamine Receptor Agonist in a Rat Model of Parkinson's Disease

Amit G. Gulwadi, Carolyn D. Korpinen, Richard B. Mailman et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 49 citations

Rows per page

1–5 of 18